Patients in the intensive care unit with valvular diseases;Patienten mit Klappenvitium auf der Intensivstation

Medizinische Klinik - Intensivmedizin und Notfallmedizin

Volumn 108, Issue 7, 2013, Pages 555-560

  Geppert, A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Baloon valvuloplasty; Cardiogenic shock; Extracorporeal membrane oxygenation; Heart assist devices; Heart valves

Indexed keywords

HYPERTENSIVE FACTOR; INOTROPIC AGENT;

AORTA VALVE STENOSIS; ARTICLE; CLIP; DRUG TREATMENT FAILURE; EXTRACORPOREAL OXYGENATION; HEART ASSIST DEVICE; HEART HEMODYNAMICS; HEART VALVE REPLACEMENT; HUMAN; INTENSIVE CARE UNIT; MITRAL VALVE; PRACTICE GUIDELINE; TRANSLUMINAL VALVULOPLASTY; VALVULAR HEART DISEASE; ECHOCARDIOGRAPHY; HEART FAILURE; HEART VALVE DISEASES; SHOCK, CARDIOGENIC; SURGERY;

BALLOON VALVULOPLASTY; ECHOCARDIOGRAPHY; EXTRACORPOREAL MEMBRANE OXYGENATION; GUIDELINE ADHERENCE; HEART FAILURE; HEART VALVE DISEASES; HUMANS; INTENSIVE CARE UNITS; MITRAL VALVE; SHOCK, CARDIOGENIC;

EID: 84886778208     PISSN: 21936218     EISSN: 21936226     Source Type: Journal    
DOI: 10.1007/s00063-012-0140-z     Document Type: Article

References (25)

1. Nieminen MS, Harjola V P, Hochadel M et al (2008) Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II. Eur J Heart Fail 10(2):140-148
2. Vahanian A, Alfieri O, Andreotti F et al (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33(19):2451-2496
3. Hoefer D, Jonetzko P, Hoermann C et al (2006) Successful administration of levosimendan in a patient with low-gradient low-output aortic stenosis. Wien Klin Wochenschr 118(1-2):60-62
4. Heuser RR, Maddoux GL, Goss JE et al (1987) Coronary angioplasty for acute mitral regurgitation due to myocardial infarction. A nonsurgical treatment preserving mitral valve integrity. Ann Intern Med 107(6):852-855
5. Shawl FA, Forman MB, Punja S, Goldbaum TS (1989) Emergent coronary angioplasty in the treatment of acute ischemic mitral regurgitation: long-term results in five cases. J Am Coll Cardiol 14(4):986-991
6. Davis C (2012) Percutaneous mitral valve repair in a ventilator-dependant patient. Anaesthesia 67(4):420-423
7. Khot UN, Novaro GM, Popovic ZB et al (2003) Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med 348(18):1756-1763
8. Folland ED, Kemper AJ, Khuri SF et al (1985) Intraaortic balloon counterpulsation as a temporary support measure in decompensated critical aortic stenosis. J Am Coll Cardiol 5(3):711-716
9. Gu YL, Jessurun GA, Merkhof LF, van den Zijlstra F (2007) Intra-aortic balloon counterpulsation for complex aortic stenosis in hybrid strategy. Int J Cardiol 117(1):e46-e48
10. Aksoy O, Yousefzai R, Singh D et al (2010) Cardio-genic shock in the setting of severe aortic stenosis: role for intra-aortic balloon pump support. Heart (British Cardiac Society)
11. Loebe M, Zade Asfahani WH, Petrov GP et al (2009) Surgical considerations on the use of the percutaneous ventricular assist device TandemHeart in critical aortic valve stenosis. Thorac Cardiovasc Surg 57(1):50-52
12. Frank CM, Palanichamy N, Kar B et al (2006) Use of a percutaneous ventricular assist device for treatment of cardiogenic shock due to critical aortic stenosis. Tex Heart Inst J 33(4):487-489
13. Hamid T, Eichhofer J, Clarke B, Mahadevan VS (2010) Aortic balloon valvuloplasty: is there still a role in high-risk patients in the era of percutan eous aortic valve replacement? J Interv Cardiol 23(4):358-361
14. Doguet F, Godin M, Lebreton G et al (2010) Aortic valve replacement after percutaneous valvuloplas-ty - an approach in otherwise inoperable patients. Eur J Cardiothorac Surg 38(4):394-399
15. Dandale R, Pesarini G, Santini F et al (2012) Is trans-femoral aortic valve implantation possible without contrast medium in patients with renal and multi-organ failure? Future Cardiol 8(4):543-546
16. Chatterjee K, Parmley WW, Swan HJ et al (1973) Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subval-var apparatus. Circulation 48(4):684-690
17. Pleger ST, Chorianopoulos E, Krumsdorf U et al (2012) Percutaneous edge-to-edge repair of mitral regurgitation as a bail-out strategy in critically ill patients. J Invasive Cardiol 25(2):69-72
18. Bilge M, Alemdar R, Yasar AS (2013) Successful percutaneous mitral valve repair with the mitraclip system of acute mitral regurgitation due to papillary muscle rupture as complication of acute myo-cardial infarction. Catheter Cardiovasc Interv
19. Bonow RO, Carabello BA, Chatterjee K et al (2008) Focused update incorporated into the ACC/ AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 52(13):e1-e142
20. Kim JB, Jung SH, Choo SJ et al (2012) Clinical and echocardiographic outcomes after surgery for severe isolated tricuspid regurgitation. J Thorac Cardiovasc Surg
21. Lauten A, Figulla HR, Willich C et al (2010) Hetero-topic valve replacement as an interventional approach to tricuspid regurgitation. J Am Coll Cardiol 55(5):499-500
22. Lauten A, Jung C, Rademacher W et al (2009) Management of tricuspid valve disease. Dtsch Med Wochenschr (1946) 134(44):2239-2244
23. Lauten A, Ferrari M, Hekmat K et al (2011) Hete-rotopic transcatheter tricuspid valve implantation: first-in-man application of a novel approach to tricuspid regurgitation. Eur Heart J 32(10):1207-1213
24. Geppert A (2011) Therapie des nichtinfarktbeding-ten kardiogenen Schocks. Intensivmed Notfallmed 48:259-263
25. Werdan K, Ruß M, Buerke M, Engelmann L et al. (2011) Deutsch-österreichische S3-Leitlinie In- farktbedingter kardiogener Schock - Diagnose, Monitoring und Therapie. Intensive med Notfallmed 48:291-344